ORTINGLOBE
ORTIN GLOBAL LIMITED (ORTINGLOBE) Stock Analysis
Ortin Global Limited is a pharmaceutical company engaged in formulations and drug distribution in India. It markets generic medicines and healthcare products through trade channels. The business focuses on affordable pharma supply. It is listed on Indian stock exchanges.
Healthcare › Drug Manufacturers - Specialty & Generic
₹14.30
+3.69% 1W | +24.60% 52W
Market Cap
12 CR
P/E Ratio
–
52W High
₹21.3
52W Low
₹10.7
Div. Yield
0%
Beta
0.5
50 DMA
₹15.3
200 DMA
₹15.3
Profit Margin
0%
Inst. Own.
0%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2011 | Mar 2012 | Jun 2012 |
|---|---|---|---|
| Sales | 19.81 | 19.77 | 15.93 |
| Expenses | 17.13 | 20.77 | 13.85 |
| Operating Profit | 2.68 | -1.00 | 2.08 |
| OPM % | 13.53% | -5.06% | 13.06% |
| Other Income | 0.01 | 0.19 | 0.03 |
| Interest | 0.55 | 0.98 | 1.12 |
| Depreciation | 0.34 | 0.39 | 0.33 |
| Profit before tax | 1.80 | -2.18 | 0.66 |
| Tax % | 33.33% | -11.93% | 33.33% |
| Net Profit | 1.20 | -1.92 | 0.44 |
| EPS in Rs | 3.24 | -1.14 | 0.26 |
No annual data
Shareholding Pattern
Promoters1.23%
FIIs1.68%
Public97.08%
Promoters1.23%
FIIs1.68%
Public97.09%
Promoters1.23%
FIIs1.68%
Public97.10%
Promoters1.23%
FIIs1.80%
Public96.96%
Promoters1.24%
FIIs0.67%
Public98.09%
Promoters21.51%
Public78.49%
Promoters1.23%
Public98.76%
Promoters1.23%
FIIs6.53%
Public92.24%
Promoters1.23%
FIIs1.68%
Public97.10%
Promoters1.24%
FIIs0.67%
Public98.09%
ORTINGLOBE
Holdings Analysis
Key strengths & risk signals
42
Overall
24
Fundamental
60
Technical
Risks (4)
LOW MARGIN! 0% profit margin - thin profits.
WEAK POSITION! Current price (14.3) is below both moving averages.
BEARISH TREND! 50-day average (15.3) is below 200-day average (15.3) - negative signal.
LOWER HALF! Trading at 34.0% of 52W range - weakness visible.
Strengths (3)
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 15,885 vs down days: 12,299. Ratio: 1.29x
GOOD YEAR! Stock gained 24.6% in the last year.
Fundamental & Technical Analysis
42Overall
24Fundamental
60Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: -74.4% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
0/10
LOW MARGIN! 0% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 92.63% public ownership - higher volatility risk.
Stability Index
2/10
CAUTION! Company made loss in last quarter. Be careful.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (15.3) is below 200-day average (15.3) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (14.3) is below both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
8/10
GOOD YEAR! Stock gained 24.6% in the last year.
Volume Sentiment
25/30
BULLISH SENTIMENT! In last 30 days: 14 up days, 16 down days. Avg volume on up days: 15,885 vs down days: 12,299. Ratio: 1.29x
RSI
3/5
NEUTRAL! RSI at 45.5 - balanced momentum.
52W Range
2/5
LOWER HALF! Trading at 34.0% of 52W range - weakness visible.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - 3.7% (1 week), -16.9% (1 month), -7.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.50 - stable stock, less market risk.
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORTINGLOBE | ₹14.30 | – | – | -74.4% | – | +24.6% | 42 | APPROACHING SUPPORT | +50.0% | – | – | – |
| LASA | ₹5.10 | – | -253.8% | -42.1% | – | -48.9% | 30 | BREAKDOWN | -82.9% | -14.3% | -94.0% | -1,300.0% |
| MANGALAM | ₹31.10 | – | -16.5% | -14.3% | – | -53.8% | 41 | APPROACHING SUPPORT | -44.9% | -43.3% | -0.2% | -15.2% |
| BIOFILCHEM | ₹30.20 | 177.5 | 1.4% | -1.9% | 70.7% | -24.7% | 53 | BREAKDOWN | -95.8% | -50.0% | +93.8% | +63.2% |
| VIVIMEDLAB | ₹6.60 | – | -231.3% | -27.9% | – | +38.2% | 49 | CONSOLIDATION | +2,526.8% | +786.1% | -53.1% | -25.0% |
| VAISHALI | ₹7.80 | – | 4.1% | 18.0% | -15.2% | -22.7% | 51 | BREAKDOWN | – | +278.0% | – | -15.0% |
| ALPA | ₹53.50 | 31.8 | 3.8% | 4.3% | 6.1% | -34.9% | 47 | BREAKDOWN | -91.5% | -28.6% | +25.1% | -23.9% |
| BALAXI | ₹22.10 | 49.1 | 0.9% | -7.1% | -68.6% | -46.1% | 48 | APPROACHING SUPPORT | +333.3% | +116.7% | +14.1% | +14.1% |
Data from TradeAlone · Updated daily
No news tagged for ORTINGLOBE yet.
